Francesco Gelsomino

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

Lorenza Landi, Federica D’Incà, Alain Gelibter et al. · Journal for ImmunoTherapy of Cancer · 2019 · 171 citations · Full text

Medicine, Immunology, Oncology +12

The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC

Giulia Mazzaschi, Francesco Facchinetti, Gabriele Missale et al. · Lung Cancer · 2018 · 136 citations

Life Sciences, Immunology, Oncology +17

EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinib-resistant patient with both concomitant mutations

Marcello Tiseo, Francesco Gelsomino, Daniela Boggiani et al. · Lung Cancer · 2010 · 126 citations

Medicine, Genetics, Oncology +17

Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With <i>BRAF</i>^V600-Mutant Metastatic Non–Small-Cell Lung Cancer

Gregory J. Riely, Egbert F. Smit, Myung‐Ju Ahn et al. · Journal of Clinical Oncology · 2023 · 114 citations · Full text

Medicine, Oncology, Pharmacology +17

STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?

Alessandro Di Federico, Andrea De Giglio, Claudia Parisi et al. · European Journal of Cancer · 2021 · 108 citations · Full text

Medicine, Genetics, Oncology +12